Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Medicare

Reports

Displaying 1 - 10 of 152. 10 per page. Page 1.

Advanced Search
Research Brief

Associations Between County-level Vaccination Rates and COVID-19 Outcomes Among Medicare Beneficiaries

October 5, 2021
The purpose of this study is to identify associations between COVID-19 infections, hospitalizations, and deaths among Medicare fee-for-service (FFS) beneficiaries and the proportion of the population fully vaccinated at the county-level between January and May 2021.
Report

Building the Evidence Base for Social Determinants of Health Interventions

September 23, 2021
In an effort to help build the evidence base around the social determinants of health (SDOH), the Assistant Secretary for Planning and Evaluation (ASPE) engaged RAND in a project to evaluate the current evidence from programs and policies targeting SDOH and identify the SDOH research questions, data sources, and data gaps that might be used to develop an SDOH research agenda.
ASPE Issue Brief

Air Ambulance Use and Surprise Billing

September 10, 2021
Air ambulances are used to transport patients in critical situations from the scene of an injury or accident to hospitals, or between hospitals.
ASPE Issue Brief

State Medicaid Telehealth Policies Before and During the COVID-19 Public Health Emergency

July 19, 2021
States have embraced Medicaid telehealth flexibilities during the COVID-19 Public Health Emergency (PHE), enhancing beneficiary access to services delivered via telehealth. This Issue Brief examines state Medicaid telehealth coverage and policies before and after the COVID-19 PHE was declared in January 2020. Related Products
ASPE Issue Brief

The Impact of the COVID-19 Pandemic on Medicare Beneficiary Utilization and Provider Payments: Fee-For-Service (FFS) Data for 2020

June 28, 2021
Medicare FFS beneficiary service use and associated payments to providers dropped substantially from mid-March through mid-April, but had returned to near-2019 levels by the fall of 2020. The rebound in the fall was not sufficient to offset the earlier declines in the spring, and cumulative payment levels across all states were lower in 2020 compared to 2019.
ASPE Issue Brief

The Impact of COVID-19 on Medicare Beneficiaries with Dementia Issue Brief

April 7, 2021
April 6, 2021 Link to Printer Friendly Version in PDF Format (11 PDF pages)

Risk of COVID-19 Infections, Hospitalization, and Death in Fee-For-Service Medicare

March 18, 2021
Experience during the first six months of the pandemic shows that the risks of Medicare fee-for-service (FFS) beneficiaries contracting COVID-19 and subsequent hospitalization and mortality vary significantly by demographic characteristics, health status, and nursing home residence. There are several factors that indicate significantly elevated risk.
ASPE Issue Brief

Medicare Part D: Competition and Generic Drug Prices, 2007-2018

January 26, 2021
The United States relies on the interactions of private entities – drug manufacturers, health plans and pharmaceutical benefit managers (PBMs) - to achieve value by negotiating prices, operating formularies and implementing other benefit management strategies. The U.S. does not establish or negotiate prices for prescription drugs, as do some other countries. A critical part of the U.S.

Medicare: Opportunities for Market-Based Policies

January 14, 2021
Market-based payment policies such as competitive bidding, reference pricing, centers of excellence and tiered provider networks have been implemented both in Medicare and across the private sector, as described in this report required by Executive Order 13890.

Medicare FFS Part B and International Drug Prices: A Comparison of the Top 50 Drugs

November 19, 2020
The September 13, 2020 Executive Order on Lowering Drug Prices by Putting America First declared, “It is the policy of the United States that the Medicare program should not pay more for costly Part B or Part D prescription drugs or biological products than the most-favored-nation price.” The Most Favored Nation (MFN) Model issued by the Centers for Medicare & Medicaid Services (CMS) on No